
Source: FirstWord
Social media is evolving rapidly. What was once seen as "nice to have" is now considered a "must have" and businesses can no longer ignore the medium in all its guises. Keeping up to date with what is being written about your company and brands on social media channels is key. Not only do you need to know what people are talking about and how people "view" your company, you also need to be in a position to respond to negative comments quickly and effectively.
—————
Source: Medical Marketing & Media
Last April, the FDA issued letters to 14 pharma companies for failure to present risk information in paid search placements. New draft guidance on presenting risk information for TV and print followed in May, but guidance on online promotion remains wanting...
—————
Source: Med Ad News
IRVINE, CA, February 24, 2010 – Ignite Health, an inVentiv Health company, (NASDAQ: VTIV) and a leading marketing agency that specializes in patient-centered medical advertising, recently promoted Matt Brown to President. His former position was Chief Operating Officer. Jackie Herr, co-founder and former President of Ignite, will be retiring from Ignite at the end of March.
—————
Source: FDASM
Ignite Health’s Fabio Gratton, Chief Innovation Officer, had the unique opportunity on January 28 to speak exclusively with Dr. Jean-Ah Kang at the FDA’s Silver Spring, MD office as a follow-up to the Part 15 Public Hearings on the use of the Internet and social media to promote FDA-regulated medical products. Dr. Kang is Special Assistant to the Director in the Division of Drug Marketing, Advertising and Communications (DDMAC), the government organization managing the hearing process. The two-hour interview focused on the ongoing development of FDA regulations to govern promotion, as well as the results of the hearings and what the pharmaceutical industry can do to participate in the guidance process.
—————
Source: PharmaVOICE
Fabio Gratton, Chief Innovation Officer for Ignite, is featured in "The Last Word" for the January 2010 issue of PharmaVOICE. In the article Gratton discusses his experience presenting at the November 2009 FDA public hearing on social media, as well as what the industry should do next, and how the changing landscape of Web 2.0 has become a hot button priority for many pharma companies.
Fabio Gratton
Ignite Health(949) 870-9702
Multilanguage free website :: Webnode